What determines the use of complementary therapies by Canadian cancer patients?

Anne Leis(Saskatchewan Health Authority), R.A.D. Dewar(Nova Scotia Cancer Centre), L Tan(University of Saskatchewan), MJ Verhoef(University of Calgary), Richard Doll(St Thomas' Hospital), M Deschamps(Institut National de Santé Publique du Québec)
Focus on Alternative and Complementary Therapies
March 1, 2003
10.1111/j.2042-7166.2003.tb05811.x
Cited by 7

Related Papers

Radon in homes and risk of lung cancer: collaborative analysis of individual data from 13 European case-control studies
|BMJ|2004|1.8k
Mortality in relation to smoking: 22 years' observations on female British doctors.
|BMJ|1980|353
Complementary and alternative medicine whole systems research: Beyond identification of inadequacies of the RCT
|Complementary Therapies in Medicine|2005|272
Breast cancer and abortion: collaborative reanalysis of data from 53 epidemiological studies, including 83 000 women with breast cancer from 16 countries
|The Lancet|2004|234
Mortality among patients with ankylosing spondylitis after a single treatment course with x rays.
|BMJ|1982|231